Tianjing Li: What’s not shared—building on the FDA’s transparency momentum

Recently, the US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, announced new steps that the agency is taking to enhance transparency of clinical trial information. The FDA is launching a pilot programme whereby selected portions of clinical study reports (CSRs) for nine recently approved new drug applications will be posted on the agency’s website. […]

Read More…

Sofia Gruskin: We must follow California’s example and repeal archaic HIV laws

Recently, my home state of California made national headlines when it repealed an HIV criminalisation law and reduced penalties for exposing other people to the virus. It was a landmark decision grounded in science and human rights that will go into effect next month. The law that was repealed had violated people’s fundamental human rights […]

Read More…